CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis
Europe - Euronext Oslo - OSL:CONTX - SE0014731154 - Common Stock
3.85 NOK
-0.04 (-1.03%)
CONTX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 10 industry peers in the Health Care Technology industry. CONTX has an average financial health and profitability rating. CONTX is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
CONTX had positive earnings in the past year.
In the past year CONTX had a positive cash flow from operations.
Of the past 5 years CONTX 4 years were profitable.
Each year in the past 5 years CONTX had a positive operating cash flow.
1.2 Ratios
CONTX has a Return On Assets (3.07%) which is in line with its industry peers.
CONTX's Return On Equity of 3.95% is in line compared to the rest of the industry. CONTX outperforms 50.00% of its industry peers.
The Return On Invested Capital of CONTX (2.67%) is worse than 60.00% of its industry peers.
CONTX had an Average Return On Invested Capital over the past 3 years of 36.72%. This is significantly above the industry average of 8.41%.
The 3 year average ROIC (36.72%) for CONTX is well above the current ROIC(2.67%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.07% | ||
| ROE | 3.95% | ||
| ROIC | 2.67% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
1.3 Margins
Looking at the Profit Margin, with a value of 3.17%, CONTX is in line with its industry, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Profit Margin of CONTX has grown nicely.
Looking at the Operating Margin, with a value of 2.90%, CONTX is doing worse than 60.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CONTX has grown nicely.
CONTX's Gross Margin of 97.62% is amongst the best of the industry. CONTX outperforms 90.00% of its industry peers.
In the last couple of years the Gross Margin of CONTX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.9% | ||
| PM (TTM) | 3.17% | ||
| GM | 97.62% |
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
CONTX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for CONTX remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CONTX has about the same amount of shares outstanding.
Compared to 1 year ago, CONTX has a worse debt to assets ratio.
2.2 Solvency
The Debt to FCF ratio of CONTX is 5.01, which is a neutral value as it means it would take CONTX, 5.01 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CONTX (5.01) is comparable to the rest of the industry.
CONTX has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CONTX (0.07) is better than 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 5.01 | ||
| Altman-Z | N/A |
ROIC/WACC0.38
WACC7.07%
2.3 Liquidity
CONTX has a Current Ratio of 4.79. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.79, CONTX belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
A Quick Ratio of 4.70 indicates that CONTX has no problem at all paying its short term obligations.
CONTX has a Quick ratio of 4.70. This is amongst the best in the industry. CONTX outperforms 90.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.79 | ||
| Quick Ratio | 4.7 |
3. Growth
3.1 Past
The earnings per share for CONTX have decreased strongly by -83.70% in the last year.
Measured over the past years, CONTX shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.26% on average per year.
The Revenue for CONTX has decreased by -13.08% in the past year. This is quite bad
CONTX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.51% yearly.
EPS 1Y (TTM)-83.7%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-100%
Revenue 1Y (TTM)-13.08%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-21.24%
3.2 Future
CONTX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -7.44% yearly.
Based on estimates for the next years, CONTX will show a small growth in Revenue. The Revenue will grow by 0.49% on average per year.
EPS Next Y-103.45%
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%
EPS Next 5YN/A
Revenue Next Year-17.19%
Revenue Next 2Y-6.46%
Revenue Next 3Y-3.79%
Revenue Next 5Y0.49%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CONTX is valuated quite expensively with a Price/Earnings ratio of 77.00.
CONTX's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of CONTX to the average of the S&P500 Index (27.19), we can say CONTX is valued expensively.
A Price/Forward Earnings ratio of 31.01 indicates a quite expensive valuation of CONTX.
The rest of the industry has a similar Price/Forward Earnings ratio as CONTX.
When comparing the Price/Forward Earnings ratio of CONTX to the average of the S&P500 Index (23.92), we can say CONTX is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 77 | ||
| Fwd PE | 31.01 |
4.2 Price Multiples
CONTX's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CONTX indicates a slightly more expensive valuation: CONTX is more expensive than 60.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 162.5 | ||
| EV/EBITDA | 19.4 |
4.3 Compensation for Growth
The decent profitability rating of CONTX may justify a higher PE ratio.
CONTX's earnings are expected to decrease with -7.44% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)2.82
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%
5. Dividend
5.1 Amount
CONTX has a Yearly Dividend Yield of 4.18%, which is a nice return.
Compared to an average industry Dividend Yield of 1.99, CONTX pays a better dividend. On top of this CONTX pays more dividend than 90.00% of the companies listed in the same industry.
CONTX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%
OSL:CONTX (1/12/2026, 3:52:03 PM)
3.85
-0.04 (-1.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap297.87M
Revenue(TTM)112.76M
Net Income(TTM)3.58M
Analysts40
Price Target4.08 (5.97%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-100%
Min EPS beat(2)-100%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.52%
Min Revenue beat(2)-22.13%
Max Revenue beat(2)-4.91%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-20%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)50%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 77 | ||
| Fwd PE | 31.01 | ||
| P/S | 2.41 | ||
| P/FCF | 162.5 | ||
| P/OCF | 30.6 | ||
| P/B | 3 | ||
| P/tB | 3.09 | ||
| EV/EBITDA | 19.4 |
EPS(TTM)0.05
EY1.3%
EPS(NY)0.12
Fwd EY3.22%
FCF(TTM)0.02
FCFY0.62%
OCF(TTM)0.13
OCFY3.27%
SpS1.6
BVpS1.28
TBVpS1.25
PEG (NY)N/A
PEG (5Y)2.82
Graham Number1.2
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.07% | ||
| ROE | 3.95% | ||
| ROCE | 3.38% | ||
| ROIC | 2.67% | ||
| ROICexc | 8.83% | ||
| ROICexgc | 9.67% | ||
| OM | 2.9% | ||
| PM (TTM) | 3.17% | ||
| GM | 97.62% | ||
| FCFM | 1.48% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexgc growth 3Y-39.35%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score5
Asset Turnover0.97
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 5.01 | ||
| Debt/EBITDA | 0.55 | ||
| Cap/Depr | 92.01% | ||
| Cap/Sales | 6.39% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.95% | ||
| Profit Quality | 46.76% | ||
| Current Ratio | 4.79 | ||
| Quick Ratio | 4.7 | ||
| Altman-Z | N/A |
F-Score5
WACC7.07%
ROIC/WACC0.38
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-83.7%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-100%
EPS Next Y-103.45%
EPS Next 2Y-38.41%
EPS Next 3Y-7.44%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.08%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-21.24%
Revenue Next Year-17.19%
Revenue Next 2Y-6.46%
Revenue Next 3Y-3.79%
Revenue Next 5Y0.49%
EBIT growth 1Y-87.72%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-25%
EBIT Next 3Y6.69%
EBIT Next 5YN/A
FCF growth 1Y-95.22%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-79.63%
OCF growth 3Y51.49%
OCF growth 5Y5.6%
CONTEXTVISION AB / CONTX.OL FAQ
What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL.
What is the valuation status for CONTX stock?
ChartMill assigns a valuation rating of 2 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Overvalued.
What is the profitability of CONTX stock?
CONTEXTVISION AB (CONTX.OL) has a profitability rating of 7 / 10.
What is the financial health of CONTEXTVISION AB (CONTX.OL) stock?
The financial health rating of CONTEXTVISION AB (CONTX.OL) is 6 / 10.
What is the expected EPS growth for CONTEXTVISION AB (CONTX.OL) stock?
The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to decline by -103.45% in the next year.